Zacks.com on MSN19h
CHMP Endorses AstraZeneca's Tagrisso for Expanded Use in NSCLC
AstraZeneca AZN announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) recommended approving its ...
STAT7d
Pharmalittle: We’re reading about 23andMe retrenching, AstraZeneca reworking cancer drug plans, and more
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
STAT13d
AstraZeneca says China has detained a senior executive
The company believes Chinese authorities are probing allegations that two current and two former employees had illegally ...
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Reuters7d
AstraZeneca: 450 million pound investment in UK under review amid talks with govt
LONDON, Nov 12 (Reuters) - London-listed drugmaker AstraZeneca (AZN.L), opens new tab said its plan to invest 450 million ...
AstraZeneca’s Tagrisso Gains EU Approval Nod
AstraZeneca (GB:AZN) has released an update.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top Wall Street ...
AstraZeneca Says Current, Former Executives Involved in China Probe
Two current and two former senior AstraZeneca Plc executives in the group’s China unit are under investigation in a probe ...
India Infoline1d
AstraZeneca to introduce COPD inhaler Breztri Aerosphere in India
This combination drug is used to treat chronic obstructive pulmonary disease in adults, relieving symptoms and preventing ...
Business Insider2d
Lunit announces collaboration with AstraZeneca to develop AI-powered tools
Lunit announced a strategic collaboration with AstraZeneca (AZN) to develop AI-powered digital pathology solutions. The solution in focus is Lunit SCOPE Genotype Predictor, an AI-powered tool ...